HIND
Vyome Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.10
+7.14%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.97
From 52W high−68.23%
Volume175374.00
Market cap$14.74M
P/E (TTM)—
P/S (TTM)113.6x
Div yield—
Key dataSep 18, 2026
Open
$1.97
From 52W high
−68.23%
Volume
175374.00
Market cap
$14.74M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.7x
P/E (TTM)
—
RSI (14)
38.3
MomentumView details →
1D Return
+7.14%
YTD Return
−41.86%
Similar companies
Latest newsMore news →
Vyome Holdings appointed Jerry Leonard as Chief Financial Officer, effective September 1, 2026, succeeding Robert Dickey, who resigned as Interim Chief Financial Officer effective August 31, 2026.23d agoVyome Holdings reported Q2 2026 revenue of $58,546, a net loss of $720,000, and a diluted loss per share of $0.10, with cash and cash equivalents of $7.9 million as of the period end.27d ago